TORONTO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results